Clinical trial · Interventional
Blue Note Therapeutics Product BNT 103 Usability and User Engagement
BNT 103 Usability and User Engagement
NCT05032404CI-TRIAL-00061530completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This test aims to explore product development-focused usability and user engagement.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| BNT103 | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- BNT103
- description
- All participants receive BNT103. BNT103 provides 10 sessions over approximately 10 weeks.
- interventionNames
- Device: BNT103
Primary outcomes (1)
- measure
- Mean mHealth App Usability Questionnaire (MAUQ) for Standalone mHealth Apps Used by Patients
- timeFrame
- Baseline up to Week 7
- description
- Higher scores indicate higher ease of use / easier to use applications
Secondary outcomes (1)
- measure
- Measure of Current Status - Anxiety (MOCS-A)
- timeFrame
- Baseline up to Week 7
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 35 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * Patient can read, write, and speak in English * Patient is between the ages of 35-55 * Diagnosed with Stage I-III breast cancer * In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study * Apple mobile phone or tablet user * Willing to participate in study protocol Exclusion Criteria: * Any participant not meeting inclusion criteria
References
Publications (1)
- BACKGROUNDAntoni MH, Lechner S, Diaz A, Vargas S, Holley H, Phillips K, McGregor B, Carver CS, Blomberg B. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun. 2009 Jul;23(5):580-91. doi: 10.1016/j.bbi.2008.09.005. Epub 2008 Sep 20. PMID 18835434